Matthew B. Frankel
Directeur Technique/Scientifique/R&D chez CHEMOMAB THERAPEUTICS LTD.
Fortune : - $ au 30/04/2024
Postes actifs de Matthew B. Frankel
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| CHEMOMAB THERAPEUTICS LTD. | Directeur Technique/Scientifique/R&D | 14/11/2022 | - |
Historique de carrière de Matthew B. Frankel
Anciens postes connus de Matthew B. Frankel
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Boehringer Ingelheim Pharmaceuticals, Inc.
 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Directeur Technique/Scientifique/R&D | 01/01/2018 | 01/11/2022 |
Formation de Matthew B. Frankel
| Vassar College | Undergraduate Degree |
| David Geffen School of Medicine | Doctorate Degree |
| Kellogg School of Management | Masters Business Admin |
Statistiques
Internationale
| Etats-Unis | 5 |
| Israël | 2 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 2 |
| Undergraduate Degree | 1 |
| Doctorate Degree | 1 |
Sectorielle
| Consumer Services | 4 |
| Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CHEMOMAB THERAPEUTICS LTD. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Health Technology |
- Bourse
- Insiders
- Matthew B. Frankel
- Expérience